Patent EP0176728B1 successfully refreshed from Google Patents.
← Back to Patent Explorer
US3985884A Expired / Lapsed US ⏱️ 0.0 years remaining

Complement inhibitors

Assignee: Wyeth Holdings LLC
•
Filing: 1975-12-12
•
Granted: 1976-10-12
•
Expires: 1995-12-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 3,3'-ureylenebis[6-(hydroxysulfo-2H-naphtho[1,2-d]-triazol-2-yl)benzen esulfonic acids] and salts useful as complement inhibitors.

Inventors

  • 👤 Ransom Brown Conrow
  • 👤 Seymour Bernstein

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 10:54
CPC Classifications
C; C07; C07D; C07D249/00; C07D249/16; C07D249/22

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 28 words
A compound selected from those of the formula: ##SPC4## wherein A is H, Na or K, with the proviso that each A is identical in the same compound.
Claim 2
Dependent Claim 28 words
A compound selected from those of the formula: ##SPC4## wherein A is H, Na or K, with the proviso that each A is identical in the same compound.
Claim 3
Dependent Claim 9 words
A compound selected from those of the formula: ##SPC5##
Claim 4
Dependent Claim 9 words
A compound selected from those of the formula: ##SPC5##
Claim 5
Dependent Claim 14 words
A compound according to claim 2, 3,3'-ureylene-bis[6-(9-hydroxy-7-sulfo-2H-naphtho[1,2-d]triazol-2-yl)benzenesulfonic acid] tetrasodium salt of the formula: ##SPC6##
Claim 6
Independent Claim 52 words
A method of inhibiting the complement system in a body fluid which comprises subjecting said body fluid to the action of an effective complement inhibiting amount of a compound of the formula: ##SPC7## wherein A is H, Na or K, with the proviso that each A is identical in the same compound.
Claim 7
Independent Claim 52 words
A method of inhibiting the complement system in a body fluid which comprises subjecting said body fluid to the action of an effective complement inhibiting amount of a compound of the formula: ##SPC7## wherein A is H, Na or K, with the proviso that each A is identical in the same compound.
Claim 8
Dependent Claim 14 words
A method according to claim 4, wherein the compound is 3,3'-ureylenebis[6-(9-hydroxy-7-sulfo-2H-naphtho-[1,2-d]triazol-2-yl)benzenesulfonic acid] tetrasodium salt.
Claim 9
Independent Claim 49 words
A method of inhibiting the complement system in a warm-blooded animal which comprises internally administering to said animal an effective complement inhibiting amount of a compound of the formula: ##SPC8## wherein A is H, Na or K, with the proviso that each A is identical in the same compound.
Claim 10
Independent Claim 49 words
A method of inhibiting the complement system in a warm-blooded animal which comprises internally administering to said animal an effective complement inhibiting amount of a compound of the formula: ##SPC8## wherein A is H, Na or K, with the proviso that each A is identical in the same compound.
Claim 11
Dependent Claim 14 words
A method according to claim 6 wherein the compound is 3,3'-ureylenebis[6-(9-hydroxy-7-sulfo-2H-naphtho-[1,2-d]triazol-2-yl)benzenesulfonic acid] tetrasodium salt.

References Cited (Backward Citations)

US2799671A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-10-12 1980-04-12 1980-10-12 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-10-12 1984-04-12 1984-10-12 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-10-12 1988-04-12 1988-10-12 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag